CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
107 hedge funds and large institutions have $3.27B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $4.25B → $3.27B (-$981M)
Holders
107
Holding in Top 10
3
Calls
$14.2M
Puts
$10.3M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$11.9M | |
| 3 | +$11.2M | |
| 4 |
Morgan Stanley
New York
|
+$7.39M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$7.22M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.25M | |
| 3 | -$4.81M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.68M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.88M |